Azitra, Inc.

AMEX:AZTR

Biotechnology

Healthcare
$1.53 +113.99%

+$0.82 today

Market cap
$92.72M
Beta
-1.04
P/E (TTM)
-1.2
EPS (TTM)
-$0.64
52W Low $0.05High $2.13

Volume 146.25M

Average 11.12M

AZTR Common Stock Issued

Cash raised by issuing new shares.

Azitra, Inc.AMEX: AZTR

Common Stock Issued · Q2 FY2026 · quarter ended Jun 2026

Common stock issued dips below year-ago levels

Q2 FY2026 common stock issued of $190.31K fell 72.6% year over year, behind the +51.0% change in trailing-twelve-month common stock issued. Sequentially, it fell 98.2% from the prior quarter.

Context

  • Common stock issued increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -72.6% toward the trailing-twelve-month pace of +51.0%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$190.31K-98.2% QoQ
Last fiscal yearDec 2025
$9.03M-32.4% YoY
LTMJun 2026
$17.38M+51.0% YoY
Common Stock Issued past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-72.6%——
1 year-32.4%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Common Stock Issued history

USD · from the cash flow

Latest · FY2025
9.03M USD
Year-over-year change
-32.4%

Common Stock Issued vs competitors

How AZTR compares with its peers on the latest reported figures

  • AZTR's LTM Jun 2026 common stock issued of $17.38M is the largest of the 2 companies compared; the peer median is $9.39M.
  • Its year-over-year change of +51.0% is the highest of 2, against a peer median of +12.8%.
AZTR Competitors Peer median
Common Stock Issued for AZTR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AZTRAzitra, Inc.LTM Jun 2026$17.38M +51.0%——
INDPIndaptus Therapeutics, Inc.LTM Mar 2026$9.39M +12.8%——
Peer median (excluding AZTR) $9.39M+12.8%——

Competitors are the stored peer set for AZTR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(8.94M)(10.68M)(11.28M)(8.97M)(10.96M)
Depreciation & Amortization84.77K405.98K425.55K448.24K453.14K
Deferred Income Tax00000
Stock-Based Compensation306.06K184.47K151.51K245.05K62.74K
Change in Working Capital646.35K310.76K(753.43K)(441.72K)(797.23K)
Accounts Receivables194.17K66.67K42.73K133.15K(39.4K)
Inventory00000
Accounts Payables282.98K420.75K(68.68K)(140.54K)0
Other Working Capital169.2K(176.66K)(727.48K)(434.33K)(757.83K)
Other Non-Cash Items(164.86K)1.43M4.1M(1.47M)12.58K
Operating Cash Flow(8.07M)(8.35M)(7.36M)(10.18M)(11.22M)
Capital Expenditures(652.28K)(341.01K)(318.26K)(379.25K)(186.06K)
Acquisitions (Net)00000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(206.14K)(303.66K)(291.72K)(370.68K)(158.7K)
Investing Cash Flow(652.28K)(336.76K)(318.26K)(379.25K)(182.91K)
Debt Repayment984.39K4.35M(7.39K)(14.6K)(16.06K)
Common Stock Issued005.99M13.35M9.03M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities8.48K(215.38K)0(18.38K)(96.86K)
Financing Cash Flow992.86K4.13M5.98M13.32M8.92M
Effect of Forex Changes00000
Net Change in Cash(7.73M)(4.55M)(1.7M)2.76M(2.49M)
Free Cash Flow(8.72M)(8.69M)(7.68M)(10.56M)(11.41M)

Azitra, Inc.

AMEX:AZTR

Intrinsic Alpha fair value

Locked

Current Price

$1.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.